Autism is a he terogeneous syndrome that is defined by impairments in three core domains — social interaction, language and restricted and/or repetitive behaviour.
Defined mutations, genetic syndromes and de novo copy number variation probably account for about 10–20% of autism spectrum disorder (ASD) cases, with none of these known causes accounting for more than 1–2%.
None of the molecules or syndromes currently linked to the ASDs has been proven to selectively cause autism. Instead, each seems to result in an array of abnormal neurobehavioural phenotypes, including ASDs and non-syndromic mental retardation.
Understanding why these mutations lead to ASDs in only a subset of cases — through identification of genetic and/or environmental modifiers — will help to clarify how the specific aspects of cognition and behaviour are ultimately shaped.
The identification of molecular links between distinct ASD-related syndromes will lead towards the identification of key signalling pathways that are dysregulated in the ASDs.
Autism is a heterogeneous syndrome defined by impairments in three core domains: social interaction, language and range of interests. Recent work has led to the identification of several autism susceptibility genes and an increased appreciation of the contribution of de novo and inherited copy number variation. Promising strategies are also being applied to identify common genetic risk variants. Systems biology approaches, including array-based expression profiling, are poised to provide additional insights into this group of disorders, in which heterogeneity, both genetic and phenotypic, is emerging as a dominant theme.
Subscribe to Journal
Get full journal access for 1 year
only $21.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Fombonne, E. Epidemiology of autistic disorder and other pervasive developmental disorders. J. Clin. Psychiatry 66 (Suppl. 10), 3–8 (2005).
Blomquist, H. K. et al. Frequency of the fragile X syndrome in infantile autism. A Swedish multicenter study. Clin. Genet. 27, 113–117 (1985).
Jacquemont, M. L. et al. Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J. Med. Genet. 43, 843–849 (2006). The numerous de novo deletions that are reported in this work have received relatively little attention but are probably important in the ASDs. These data also show that rare de novo mutations are likely to appear at particularly high frequencies in syndromic populations.
Sebat, J. et al. Strong association of de novo copy number mutations with autism. Science 316, 445–449 (2007). Beyond identifying important CNV likely to prove important to our understanding of the ASDs, this study highlights a significant difference in the frequency of de novo variants between simplex and multiplex families, raising the possibility that distinct mechanisms are involved in each.
Szatmari, P. et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature Genet. 39, 319–328 (2007). This work — the largest ASD linkage study published to date — identifies a number of new loci that merit additional attention. Lack of overlap with previously published studies underscores the importance of genetic and phenotypic heterogeneity in ASDs.
Zoghbi, H. Y. Postnatal neurodevelopmental disorders: meeting at the synapse? Science 302, 826–830 (2003).
Geschwind, D. H. & Levitt, P. Autism spectrum disorders: developmental disconnection syndromes. Curr. Opin. Neurobiol. 17, 103–111 (2007).
Jorde, L. B. et al. Complex segregation analysis of autism. Am. J. Hum. Genet. 49, 932–938 (1991).
Bolton, P. et al. A case–control family history study of autism. J. Child Psychol. Psychiatry 35, 877–900 (1994).
Bishop, D. V. et al. Using self-report to identify the broad phenotype in parents of children with autistic spectrum disorders: a study using the Autism-Spectrum Quotient. J. Child Psychol. Psychiatry 45, 1431–1436 (2004).
Bailey, A. et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med. 25, 63–77 (1995).
Steffenburg, S. et al. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J. Child Psychol. Psychiatry 30, 405–416 (1989).
Ronald, A. et al. Genetic heterogeneity between the three components of the autism spectrum: a twin study. J. Am. Acad. Child Adolesc. Psychiatry 45, 691–699 (2006).
Alarcon, M., Cantor, R. M., Liu, J., Gilliam, T. C. & Geschwind, D. H. Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families. Am. J. Hum. Genet. 70, 60–71 (2002). This first QTL study in autism is important because of its identification of a language QTL on chromosome 7q. Subsequent work from this group shows that this effect is attributable, at least in part, to variation in CNTNAP2.
Schellenberg, G. D. et al. Evidence for multiple loci from a genome scan of autism kindreds. Mol. Psychiatry 11, 1049–1060 (2006).
Chen, G. K., Kono, N., Geschwind, D. H. & Cantor, R. M. Quantitative trait locus analysis of nonverbal communication in autism spectrum disorder. Mol. Psychiatry 11, 214–220 (2006). Variation in multiple quantitative phenotypes is likely to underlie ASD risk. These data suggest that key loci contribute to non-verbal aspects of communication in patients and highlight a heritable phenotypic measure that might prove important to characterizing the ASDs.
Constantino, J. N. et al. The factor structure of autistic traits. J. Child Psychol. Psychiatry 45, 719–726 (2004).
Zhao, X. et al. A unified genetic theory for sporadic and inherited autism. Proc. Natl Acad. Sci. USA 104, 12831–12836 (2007). This work challenges the notion that the ASDs are the result of interactions between multiple risk alleles. Modelling data produces a compelling argument for the notion that a significant proportion of ASD cases are the result of dominantly acting de novo mutations.
Vorstman, J. A. et al. Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol. Psychiatry 11, 18–28 (2006).
Marshall, C. R. et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 82, 477–488 (2008).
Durand, C. M. et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature Genet. 39, 25–27 (2007).
Moessner, R. et al. Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet. 81, 1289–1297 (2007).
Wassink, T. H. et al. Evaluation of the chromosome 2q37.3 gene CENTG2 as an autism susceptibility gene. Am. J. Med. Genet. B Neuropsychiatr. Genet. 136, 36–44 (2005).
Splawski, I. et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19–31 (2004).
Samaco, R. C., Hogart, A. & LaSalle, J. M. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet. 14, 483–492 (2005).
Watson, P. et al. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J. Med. Genet. 38, 224–228 (2001). This paper highlights the fact that the molecular classification of patients, as is the case in other disorders, will be important in our understanding of the relationships between ASD subtypes and in identifying common links between them.
Nishimura, Y. et al. Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum. Mol. Genet. 16, 1682–1698 (2007).
Jamain, S. et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nature Genet. 34, 27–29 (2003). This work provides the first evidence for an important causative role for the neuroligin genes in the ASDs.
Yan, J. et al. Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol. Psychiatry 10, 329–332 (2005).
Comoletti, D. et al. The Arg451Cys-neuroligin-3 mutation associated with autism reveals a defect in protein processing. J. Neurosci. 24, 4889–4893 (2004).
Tabuchi, K. et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71–76 (2007).
Meyer, G., Varoqueaux, F., Neeb, A., Oschlies, M. & Brose, N. The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin. Neuropharmacology 47, 724–733 (2004).
Boucard, A. A., Chubykin, A. A., Comoletti, D., Taylor, P. & Sudhof, T. C. A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins. Neuron 48, 229–236 (2005).
Feng, J. et al. High frequency of neurexin 1 beta signal peptide structural variants in patients with autism. Neurosci. Lett. 409, 10–13 (2006).
Weiss, L. A. et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358, 667–675 (2008).
Poliak, S. et al. Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron 24, 1037–1047 (1999).
Strauss, K. A. et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N. Engl. J. Med. 354, 1370–1377 (2006).
Bakkaloglu, B. et al. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am. J. Hum. Genet. 82, 165–173 (2008).
Arking, D. E. et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am. J. Hum. Genet. 82, 160–164 (2008).
Alarcon, M. et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am. J. Hum. Genet. 82, 150–159 (2008).
Abrahams, B. S. et al. Genome-wide analyses of human perisylvian cerebral cortical patterning. Proc. Natl Acad. Sci. USA 104, 17849–17854 (2007).
Sebat, J. et al. Large-scale copy number polymorphism in the human genome. Science 305, 525–528 (2004).
Losh, M., Childress, D., Lam, K. & Piven, J. Defining key features of the broad autism phenotype: A comparison across parents of multiple- and single-incidence autism families. Am. J. Med. Genet. B Neuropsychiatr. Genet. 25 July 2007 (doi: 10.1002/ajmg.b.30612).
Kumar, R. A. et al. Recurrent 16p11.2 microdeletions in autism. Hum. Mol. Genet. 17, 628–638 (2007). Together with references 20 and 35, this paper highlights an important role for genes at the 16p11 locus in a substantial proportion of ASD cases.
Sadakata, T. et al. Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients. J. Clin. Invest. 117, 931–943 (2007).
Belloso, J. M. et al. Disruption of the CNTNAP2 gene in a t(7;15) translocation family without symptoms of Gilles de la Tourette syndrome. Eur. J. Hum. Genet. 15, 711–713 (2007).
Martin, C. L. et al. Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144, 869–876 (2007).
Laumonnier, F. et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am. J. Hum. Genet. 74, 552–557 (2004).
Freitag, C. M. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol. Psychiatry 12, 2–22 (2007).
Badner, J. A. & Gershon, E. S. Regional meta-analysis of published data supports linkage of autism with markers on chromosome 7. Mol. Psychiatry 7, 56–66 (2002).
Cantor, R. M. et al. Replication of autism linkage: fine-mapping peak at 17q21. Am. J. Hum. Genet. 76, 1050–1056 (2005).
Trikalinos, T. A. et al. A heterogeneity-based genome search meta-analysis for autism-spectrum disorders. Mol. Psychiatry 11, 29–36 (2006).
Geschwind, D. H. et al. The autism genetic resource exchange: a resource for the study of autism and related neuropsychiatric conditions. Am. J. Hum. Genet. 69, 463–466 (2001).
Stone, J. L. et al. Evidence for sex-specific risk alleles in autism spectrum disorder. Am. J. Hum. Genet. 75, 1117–1123 (2004). Beyond the clear identification of the 17q risk locus, this work highlights the usefulness of considering families with only affected males separately from families with both affected males and females.
Molloy, C. A., Keddache, M. & Martin, L. J. Evidence for linkage on 21q and 7q in a subset of autism characterized by developmental regression. Mol. Psychiatry 10, 741–746 (2005).
Lamb, J. A. et al. Analysis of IMGSAC autism susceptibility loci: evidence for sex limited and parent of origin specific effects. J. Med. Genet. 42, 132–137 (2005).
Buxbaum, J. D. et al. Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity. Am. J. Hum. Genet. 68, 1514–1520 (2001).
Shao, Y. et al. Phenotypic homogeneity provides increased support for linkage on chromosome 2 in autistic disorder. Am. J. Hum. Genet. 70, 1058–1061 (2002).
Buxbaum, J. D. et al. Linkage analysis for autism in a subset families with obsessive-compulsive behaviors: evidence for an autism susceptibility gene on chromosome 1 and further support for susceptibility genes on chromosome 6 and 19. Mol. Psychiatry 9, 144–150 (2004).
Abrahams, B. S. & Geschwind, D. H. in Encyclopedia of Genetics, Genomics, Proteomics and Bioinformatics (eds Dunn, M. J., Jorde, L. B., Little, P. F. R. & Subramaniam, S.) section 1.5, p1–12 (John Wiley & Sons, 2005).
Constantino, J. N. & Todd, R. D. Autistic traits in the general population: a twin study. Arch. Gen. Psychiatry 60, 524–530 (2003).
Hoekstra, R. A., Bartels, M., Verweij, C. J. & Boomsma, D. I. Heritability of autistic traits in the general population. Arch. Pediatr. Adolesc. Med. 161, 372–377 (2007).
Kissebah, A. H. et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc. Natl Acad. Sci. USA 97, 14478–14483 (2000).
Francks, C. et al. LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Mol. Psychiatry (2007).
Fisher, S. E. et al. Independent genome-wide scans identify a chromosome 18 quantitative-trait locus influencing dyslexia. Nature Genet. 30, 86–91 (2002).
Arya, R. et al. Linkage of high-density lipoprotein-cholesterol concentrations to a locus on chromosome 9p in Mexican Americans. Nature Genet. 30, 102–105 (2002).
Menzel, S. et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nature Genet. 39, 1197–1199 (2007).
Alarcon, M., Yonan, A. L., Gilliam, T. C., Cantor, R. M. & Geschwind, D. H. Quantitative genome scan and ordered-subsets analysis of autism endophenotypes support language QTLs. Mol. Psychiatry 10, 747–757 (2005).
Duvall, J. A. et al. A quantitative trait locus analysis of social responsiveness in multiplex autism families. Am. J. Psychiatry 164, 656–662 (2007).
Campbell, D. B. et al. A genetic variant that disrupts MET transcription is associated with autism. Proc. Natl Acad. Sci. USA 103, 16834–16839 (2006).
Ferland, R. J. et al. Abnormal cerebellar development and axonal decussation due to mutations in AHI1 in Joubert syndrome. Nature Genet. 36, 1008–1013 (2004).
Stone, J. L., Merriman, B., Cantor, R. M., Geschwind, D. H. & Nelson, S. F. High density SNP association study of a major autism linkage region on chromosome 17. Hum. Mol. Genet. 16, 704–715 (2007).
Salinger, W. L., Ladrow, P. & Wheeler, C. Behavioral phenotype of the reeler mutant mouse: effects of RELN gene dosage and social isolation. Behav. Neurosci. 117, 1257–1275 (2003).
DeLorey, T. M., Sahbaie, P., Hashemi, E., Homanics, G. E. & Clark, J. D. Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder. Behav. Brain Res. 187, 207–220 (2008).
Purcell, A. E., Jeon, O. H., Zimmerman, A. W., Blue, M. E. & Pevsner, J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57, 1618–1628 (2001).
Brown, V. et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107, 477–487 (2001).
Baron, C. A. et al. Genomic and functional profiling of duplicated chromosome 15 cell lines reveal regulatory alterations in UBE3A-associated ubiquitin-proteasome pathway processes. Hum. Mol. Genet. 15, 853–869 (2006).
Hu, V. W., Frank, B. C., Heine, S., Lee, N. H. & Quackenbush, J. Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes. BMC Genomics 7, 118 (2006).
Gregg, J. P. et al. Gene expression changes in children with autism. Genomics 91, 22–29 (2007).
Bittel, D. C., Kibiryeva, N. & Butler, M. G. Whole genome microarray analysis of gene expression in subjects with fragile X syndrome. Genet. Med. 9, 464–472 (2007).
Bittel, D. C., Kibiryeva, N. & Butler, M. G. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader–Willi syndrome. Pediatrics 118, e1276–e1283 (2006).
Myers, A. J. et al. A survey of genetic human cortical gene expression. Nature Genet. 39, 1494–1499 (2007).
Krauthammer, M., Kaufmann, C. A., Gilliam, T. C. & Rzhetsky, A. Molecular triangulation: bridging linkage and molecular-network information for identifying candidate genes in Alzheimer's disease. Proc. Natl Acad. Sci. USA 101, 15148–15153 (2004).
Aerts, S. et al. Gene prioritization through genomic data fusion. Nature Biotechnol. 24, 537–544 (2006).
Glasson, E. J. et al. Perinatal factors and the development of autism: a population study. Arch. Gen. Psychiatry 61, 618–627 (2004).
Reichenberg, A. et al. Advancing paternal age and autism. Arch. Gen. Psychiatry 63, 1026–1032 (2006).
Jiang, Y. H. et al. A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am. J. Med. Genet. A 131, 1–10 (2004).
Hogart, A., Nagarajan, R. P., Patzel, K. A., Yasui, D. H. & Lasalle, J. M. 15q11–13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. Hum. Mol. Genet. 16, 691–703 (2007). These results underscore the idea that the mechanisms underlying the ASDs could be much more complex than typically appreciated; in addition to alterations in absolute levels of gene expression, the authors show that the relative expression of parental GABAA alleles is altered in the ASDs, demonstrating a role for imprinting.
Bear, M. F., Huber, K. M. & Warren, S. T. The mGluR theory of fragile X mental retardation. Trends Neurosci. 27, 370–377 (2004).
Dolen, G. et al. Correction of fragile X syndrome in mice. Neuron 56, 955–962 (2007).
Chugani, D. C. Serotonin in autism and pediatric epilepsies. Ment. Retard. Dev. Disabil. Res. Rev. 10, 112–116 (2004).
Krey, J. F. & Dolmetsch, R. E. Molecular mechanisms of autism: a possible role for Ca2+ signaling. Curr. Opin. Neurobiol. 17, 112–119 (2007).
Herbert, M. R. et al. Brain asymmetries in autism and developmental language disorder: a nested whole-brain analysis. Brain 128, 213–226 (2005).
Dapretto, M. et al. Understanding emotions in others: mirror neuron dysfunction in children with autism spectrum disorders. Nature Neurosci. 9, 28–30 (2006).
Bailey, A. et al. A clinicopathological study of autism. Brain 121, 889–905 (1998).
Courchesne, E., Carper, R. & Akshoomoff, N. Evidence of brain overgrowth in the first year of life in autism. JAMA 290, 337–344 (2003).
Mundy, P. Annotation: the neural basis of social impairments in autism: the role of the dorsal medial-frontal cortex and anterior cingulate system. J. Child Psychol. Psychiatry 44, 793–809 (2003).
Tierney, E. et al. Abnormalities of cholesterol metabolism in autism spectrum disorders. Am. J. Med. Genet. B Neuropsychiatr Genet. 141, 666–668 (2006).
Knickmeyer, R. C. & Baron-Cohen, S. Fetal testosterone and sex differences in typical social development and in autism. J. Child Neurol. 21, 825–845 (2006).
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W. & Pardo, C. A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57, 67–81 (2005).
Cook, E. H. Jr, et al. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am. J. Hum. Genet. 60, 928–934 (1997).
Matsuura, T. et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nature Genet. 15, 74–77 (1997).
Peters, S. U., Beaudet, A. L., Madduri, N. & Bacino, C. A. Autism in Angelman syndrome: implications for autism research. Clin. Genet. 66, 530–536 (2004).
Manning, M. A. et al. Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum. Pediatrics 114, 451–457 (2004).
Hatton, D. D. et al. Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP. Am. J. Med. Genet. A. 140, 1804–1813 (2006).
Ozonoff, S., Williams, B. J., Gale, S. & Miller, J. N. Autism and autistic behavior in Joubert syndrome. J. Child Neurol. 14, 636–641 (1999).
Potocki, L. et al. Characterization of Potocki–Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. Am. J. Hum. Genet. 80, 633–649 (2007).
Tierney, E. et al. Behavior phenotype in the RSH/Smith–Lemli–Opitz syndrome. Am. J. Med. Genet. 98, 191–200 (2001).
Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genet. 23, 185–188 (1999).
Baker, P., Piven, J. & Sato, Y. Autism and tuberous sclerosis complex: prevalence and clinical features. J. Autism Dev. Disord. 28, 279–285 (1998).
International Molecular Genetic Study of Autism Consortium. A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Hum. Mol. Genet. 7, 571–578 (1998).
International Molecular Genetic Study of Autism Consortium. A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am. J. Hum. Genet. 69, 570–581 (2001).
International Molecular Genetic Study of Autism Consortium. Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. Hum. Mol. Genet. 10, 973–982 (2001).
Cook, E. H. Jr., et al. Linkage-disequilibrium mapping of autistic disorder, with 15q11–13 markers. Am. J. Hum. Genet. 62, 1077–1083 (1998).
Buxbaum, J. D. et al. Association between a GABRB3 polymorphism and autism. Mol. Psychiatry 7, 311–316 (2002).
Ylisaukko-Oja, T. et al. Search for autism loci by combined analysis of Autism Genetic Resource Exchange and Finnish families. Ann. Neurol. 59, 145–155 (2006).
Persico, A. M. et al. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol. Psychiatry 6, 150–159 (2001).
Bonora, E. et al. Analysis of reelin as a candidate gene for autism. Mol. Psychiatry 8, 885–892 (2003).
Skaar, D. A. et al. Analysis of the RELN gene as a genetic risk factor for autism. Mol. Psychiatry 10, 563–571 (2005).
Serajee, F. J., Zhong, H. & Mahbubul Huq, A. H. Association of reelin gene polymorphisms with autism. Genomics 87, 75–83 (2006).
Li, H. et al. The association analysis of RELN and GRM8 genes with autistic spectrum disorder in Chinese Han population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147, 194–200 (2007).
Kilpinen, H. et al. Association of DISC1 with autism and Asperger syndrome. Mol. Psychiatry 13, 187–196 (2007).
Campbell, D. B. et al. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann. Neurol. 62, 243–250 (2007).
Ramoz, N. et al. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am. J. Psychiatry 161, 662–669 (2004).
Silverman, J. M. et al. Autism-related routines and rituals associated with a mitochondrial aspartate/glutamate carrier SLC25A12 polymorphism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147, 408–410 (2007).
Segurado, R. et al. Confirmation of association between autism and the mitochondrial aspartate/glutamate carrier SLC25A12 gene on chromosome 2q31. Am. J. Psychiatry 162, 2182–2184 (2005).
Wu, S. et al. Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Biol. Psychiatry 58, 74–77 (2005).
Lerer, E. et al. Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland Adaptive Behavior Scales and cognition. Mol. Psychiatry 25 Sept 2007 (doi: 10.1038/sj.mp.4002087).
Gharani, N., Benayed, R., Mancuso, V., Brzustowicz, L. M. & Millonig, J. H. Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder. Mol. Psychiatry 9, 474–484 (2004).
Benayed, R. et al. Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus. Am. J. Hum. Genet. 77, 851–868 (2005).
Kim, S. J. et al. Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol. Psychiatry 7, 278–288 (2002).
Devlin, B. et al. Autism and the serotonin transporter: the long and short of it. Mol. Psychiatry 10, 1110–1116 (2005).
Wassink, T. H. et al. Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch. Gen. Psychiatry 64, 709–717 (2007).
Sutcliffe, J. S. et al. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am. J. Hum. Genet. 77, 265–279 (2005).
Yonan, A. L. et al. A genomewide screen of 345 families for autism-susceptibility loci. Am. J. Hum. Genet. 73, 886–897 (2003).
Weiss, L. A. et al. Variation in ITGB3 is associated with whole-blood serotonin level and autism susceptibility. Eur. J. Hum. Genet. 14, 923–931 (2006).
Coutinho, A. M. et al. Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum. Genet. 121, 243–256 (2007).
Auranen, M. et al. A genomewide screen for autism-spectrum disorders: evidence for a major susceptibility locus on chromosome 3q25–27 Am. J. Hum. Genet. 71, 777–790 (2002).
Coon, H. et al. Evidence for linkage on chromosome 3q25–27 in a large autism extended pedigree. Hum. Hered. 60, 220–226 (2005).
Liu, J. et al. A genomewide screen for autism susceptibility loci. Am. J. Hum. Genet. 69, 327–340 (2001).
Butler, M. G. et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J. Med. Genet. 42, 318–321 (2005).
Bonaglia, M. C. et al. Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am. J. Hum. Genet. 69, 261–268 (2001).
Wilson, H. L. et al. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J. Med. Genet. 40, 575–584 (2003).
Jamain, S. et al. Linkage and association of the glutamate receptor 6 gene with autism. Mol. Psychiatry 7, 302–310 (2002).
Shuang, M. et al. Family-based association study between autism and glutamate receptor 6 gene in Chinese Han trios. Am. J. Med. Genet. B Neuropsychiatr. Genet. 131, 48–50 (2004).
Kim, S. A., Kim, J. H., Park, M., Cho, I. H. & Yoo, H. J. Family-based association study between GRIK2 polymorphisms and autism spectrum disorders in the Korean trios. Neurosci. Res. 58, 332–335 (2007).
Yirmiya, N. et al. Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills. Mol. Psychiatry 11, 488–494 (2006).
Bailey, D. B. Jr, et al. Autistic behavior in young boys with fragile X syndrome. J. Autism Dev. Disord. 28, 499–508 (1998).
Ma, D. Q. et al. Dissecting the locus heterogeneity of autism: significant linkage to chromosome 12q14. Mol. Psychiatry 12, 376–384 (2007).
Ylisaukko-oja, T. et al. Genome-wide scan for loci of Asperger syndrome. Mol. Psychiatry 9, 161–168 (2004).
Wang, L. et al. Association of the ENGRAILED 2 (EN2) gene with autism in Chinese Han population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 19 Oct 2007 (doi: 10.1002/ajmg.b.30623).
Brune, C. W. et al. Heterogeneous association between engrailed-2 and autism in the CPEA network. Am. J. Med. Genet. B Neuropsychiatr. Genet. 19 Oct 2007 (doi: 10.1002/ajmg.b.30585).
We gratefully acknowledge the families who have made these studies possible — along with the vision and leadership of AGRE and Autism Speaks. We are similarly indebted to the investigators whose work drives this field forward, many of whom we were unable to cite owing to space limitations. Thanks also to E. Herman, R. Mar-Heyming, B. Fogel and other members of the Geschwind laboratory for discussions. We also thank the anonymous reviewers. Work in the Geschwind laboratory is supported by funding from Autism Speaks, the Cure Autism Now Foundation, the National Institue of Mental Health (STAART - U54 MH68172; ACE - P50 HD055784; AGRE R01 MH64547; Asymmetry R37 MH60233) and the Tourette Syndrome Association.
- Gene association studies
A set of methods that is used to determine the correlation (positive or negative) between a defined genetic variant and a phenotype of interest.
- Whole-genome linkage study
A statistical evaluation of genetic variation throughout the genome that is used to identify polymorphic loci that segregate with a phenotype of interest.
- Copy number variation
(CNV). The insertion or deletion of a relatively large DNA fragment (>50 kb).
- Relative risk
The ratio of disease incidence in two groups of individuals that differ with regards to any associated factor (such as genetic polymorphism, environmental exposure or perinatal insult).
- Community-based cohort
A group of individuals that have been selected randomly from a population (as opposed to those showing a specific phenotype of interest).
The proportion of phenotypic variation that is attributable to inherited genetic factors (in contrast to environmental ones).
A measurable trait that is both heritable and related to a specific aspect of a condition under investigation.
- Hierarchical clustering
A statistical method in which a collection of objects (observations, individuals or risk loci) are grouped into subsets, such that those within each cluster are more closely related to one another than objects that are assigned to different clusters.
- Principal components analysis
A statistical method used to simplify data sets by transforming a series of correlated variables into a smaller number of uncorrelated factors.
The frequency with which individuals that carry an allele of a given gene will show the manifestations associated with the variant. If the penetrance of a disease allele is 100% then all individuals carrying that allele will express the associated disorder.
Showing a structural abnormality of a body part or facial feature.
A chromosomal segment that is located between the centromere and telomere.
A genetic abnormality characterized by the presence of two additional and identical DNA segment copies that are joined end to end to form a forty-seventh chromosome.
- Syndromic ASD
An ASD case that is observed in the context of a recognized syndrome (for example, fragile X syndrome).
- Mirror neuron
A neuron that is active when a subject is observing or imagining a motor movement; mirror neurons are thought to underlie imitation.
- Joint attention
Sharing interest or experience with another person by pointing or following gaze.
- Pragmatic language
Practical, social use of language.
A member of a family of postsynaptic cell-adhesion molecules that is important in regulating the balance of inhibitory and excitatory neurotransmission.
Multiplex families are those in which multiple individuals have a clinically diagnosed ASD.
Simplex families are those in which only a single individual has a clinically diagnosed ASD.
- Autistic regression
Normal development until the age of two with a subsequent loss of skills within core ASD domains.
Head circumference greater than two standard deviations above the mean (the ninety fifth percentile).
- Multiple comparisons
Refers to the problem that arises when many null hypotheses are tested and 'significant' differences are observed when in reality there are no differences.
- Frontal executive
Frontal executive function describes broad aspects of higher cognition (for example, attention, working memory and relational reasoning) that are mediated by the frontal lobe and interconnected subcortical circuitry.
About this article
Cite this article
Abrahams, B., Geschwind, D. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 9, 341–355 (2008). https://doi.org/10.1038/nrg2346
The effectiveness and adverse effects of D-cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder
Cochrane Database of Systematic Reviews (2021)
BMC Research Notes (2021)
Scientific Reports (2021)
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging (2021)
Mind the translational gap: using iPS cell models to bridge from genetic discoveries to perturbed pathways and therapeutic targets
Molecular Autism (2021)